Which is the Largest European Drug of Abuse Testing Market?

 For many people in Europe, especially emotionally disturbed teens, drugs are their best friends! But, as everyone knows, whether an addict or not, drugs are not good. Though they help people escape their troubles for a while, they lead to long-lasting ill-effects, such as risk of AIDS and hepatitis C. Due to the increasing concerns among relatives and friends about drug abuse by their loved ones, they are rapidly using methods to test the presence of such substances in the body of suspected users.



Thus, with the rising prevalence of drug abuse in the continent, the European drug of abuse testing market is predicted to grow to $3.0 billion by 2023, from $1.7 billion revenue in 2017, at a 9.6% CAGR during 2018–2023. Such kits and products can be used to determine the presence of a number of toxicants in the body, including amphetamines, opiates, alcohol, cannabis, cocaine, and ecstasy, commonly known as MDMA, which is short for its chemical formula 3,4-methylenedioxymethamphetamine.

The testing volume is rising in other settings too; for instance, laboratories generally offer more cost-effective services than hospitals, which is why an increasing number of people are preferring such centers for DOA testing. Moreover, the rules in workplaces regarding drug usage are becoming stricter, and many companies are implementing testing programs for their employees, to track any risky behavior. Similarly, concerned parents are using these tests at home, especially on troubled teenagers, among whom the usage of drugs is rising fast.

Comments

Popular posts from this blog

Huge Growth Expected in Dermacosmetics Market in Future

Increasing Occurrence of Spinal Cord Injuries Powering Sales of Exoskeletons

Why is Population Health Management Market Expected to Boom in North America in Future?